News

Zacks Small Cap Research on MSN4h
MIRA Releases Financials as Research Continues
MIRA READ THE FULL MIRA RESEARCH REPORT MIRA Pharmaceuticals (NASDAQ:MIRA) is a clinical-stage pharmaceutical company focused on the development and commercialization of a new molecular synthetic ...
Lexicon targets late 2025 Phase 3 start for pilavapadin and expands LX9851 partnership with Novo Nordisk
Lexicon Pharmaceuticals' Q1 2025 highlights include a transformative Novo Nordisk partnership, Phase 3 plans for pilavapadin in DPNP, and refocused ...
American Association of Individual Investors1d
Why Lexicon Pharmaceuticals, Inc.’s (LXRX) Stock Is Down 11.08%
Lexicon Pharmaceuticals, Inc.’s LXRX share price has dipped by 11.08%, which has investors questioning if this is right time ...
Zacks Small Cap Research on MSN2d
DWTX: Phase 2b Trial in Chemotherapy Induced Neuropathic Pain Underway…
DWTX READ THE FULL DWTX RESEARCH REPORT Business Update Phase 2b Trial of Halneuron® in CINP underway; Interim Results ...
The Manila Times2d
Best Kratom for Pain: Happy Go Leafy's Strains for Chronic Pain Relief and Natural Wellness
Searching for the best Kratom for pain? Compare top Kratom strains for pain relief, safe dosage tips, and trusted brands like Happy Go Leafy.
Frontiers2d
Mixed Pain: A challenging disease
Acute pain functions as a protective signal indicating potential or actual tissue damage, whereas chronic pain, persisting ...
Canadian Medical Association Journal3d
The effects of a provincial opioid prescribing standard on prescribing for pain in adults: an interrupted time-series analysis
Background: In 2016, the College of Physicians and Surgeons of British Columbia released a legally enforceable opioid prescribing practice standard for the treatment of chronic noncancer pain (CNCP); ...